Stay updated with breaking news from Endometrial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK announced on Monday that the European Commission has granted marketing authorisation for ‘Jemperli’, or dostarlimab, in combination with chemotherapy for certain endometrial cancers. ....
GSK said Tuesday that the U.S. Food and Drug Administration has accepted the supplemental Biologics License Application for its Jemperli endometrial cancer treatment. | June 6, 2023 ....